Literature DB >> 27421969

Adipose Gene Expression Profile Changes With Lung Allograft Reperfusion.

David J Lederer1, Jason D Christie2, Joshua M Diamond2, Selim Arcasoy1, Jamiela A McDonnough1, Joshua R Sonett3, Matthew Bacchetta3, Frank D'Ovidio3, Edward Cantu4, Christian A Bermudez4, Amika McBurnie1, Melanie Rushefski2, Laurel H Kalman2, Michelle Oyster2, Carly D'Errico2, Yoshikazu Suzuki4, Jon T Giles5, Anthony Ferrante6, Matthew Lippel7, Gopal Singh3.   

Abstract

Obesity is a risk factor for primary graft dysfunction (PGD), a form of lung injury resulting from ischemia-reperfusion after lung transplantation, but the impact of ischemia-reperfusion on adipose tissue is unknown. We evaluated differential gene expression in thoracic visceral adipose tissue (VAT) before and after lung reperfusion. Total RNA was isolated from thoracic VAT sampled from six subjects enrolled in the Lung Transplant Body Composition study before and after allograft reperfusion and quantified using the Human Gene 2.0 ST array. Kyoto Encyclopedia of Genes and Genomes pathway analysis revealed enrichment for genes involved in complement and coagulation cascades and Jak-STAT signaling pathways. Overall, 72 genes were upregulated and 56 genes were downregulated in the postreperfusion time compared with baseline. Long pentraxin-3, a gene and plasma protein previously associated with PGD, was the most upregulated gene (19.5-fold increase, p = 0.04). Fibronectin leucine-rich transmembrane protein-3, a gene associated with cell adhesion and receptor signaling, was the most downregulated gene (4.3-fold decrease, p = 0.04). Ischemia-reperfusion has a demonstrable impact on gene expression in visceral adipose tissue in our pilot study of nonobese, non-PGD lung transplant recipients. Future evaluation will focus on differential adipose tissue gene expression and the development of PGD after transplant. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  genomics; ischemia reperfusion injury (IRI); lung (allograft) function/dysfunction; lung transplantation/pulmonology; translational research/science

Mesh:

Substances:

Year:  2016        PMID: 27421969      PMCID: PMC5195853          DOI: 10.1111/ajt.13964

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  23 in total

1.  Database for mobile group II introns.

Authors:  Lixin Dai; Navtej Toor; Robert Olson; Andrew Keeping; Steven Zimmerly
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

2.  affy--analysis of Affymetrix GeneChip data at the probe level.

Authors:  Laurent Gautier; Leslie Cope; Benjamin M Bolstad; Rafael A Irizarry
Journal:  Bioinformatics       Date:  2004-02-12       Impact factor: 6.937

Review 3.  Inflammatory mechanisms in obesity.

Authors:  Margaret F Gregor; Gökhan S Hotamisligil
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

4.  Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.

Authors:  J M Diamond; D J Lederer; S M Kawut; J Lee; V N Ahya; S Bellamy; S M Palmer; V N Lama; S Bhorade; M Crespo; E Demissie; J Sonett; K Wille; J Orens; P D Shah; A Weinacker; D Weill; B A Kohl; C C Deutschman; S Arcasoy; A S Shah; J A Belperio; D Wilkes; J M Reynolds; L B Ware; J D Christie
Journal:  Am J Transplant       Date:  2011-08-22       Impact factor: 8.086

5.  Response of human mature adipocytes to hypoxia-reoxygenation.

Authors:  Seok Jong Hong; Eugene Park; Wei Xu; Shengxian Jia; Robert D Galiano; Thomas A Mustoe
Journal:  Cytotherapy       Date:  2014-09-16       Impact factor: 5.414

6.  Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.

Authors:  Rupal J Shah; Amir M Emtiazjoo; Joshua M Diamond; Patricia A Smith; David W Roe; Keith M Wille; Jonathan B Orens; Lorraine B Ware; Ann Weinacker; Vibha N Lama; Sangeeta M Bhorade; Scott M Palmer; Maria Crespo; David J Lederer; Edward Cantu; George J Eckert; Jason D Christie; David S Wilkes
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

7.  Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays.

Authors:  G K Geiss; R E Bumgarner; M C An; M B Agy; A B van 't Wout; E Hammersmark; V S Carter; D Upchurch; J I Mullins; M G Katze
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

8.  Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

Authors:  David J Lederer; Steven M Kawut; Nancy Wickersham; Christopher Winterbottom; Sangeeta Bhorade; Scott M Palmer; James Lee; Joshua M Diamond; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria Crespo; Jonathan B Orens; Joshua R Sonett; Selim M Arcasoy; Lorraine B Ware; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

9.  Bioconductor: open software development for computational biology and bioinformatics.

Authors:  Robert C Gentleman; Vincent J Carey; Douglas M Bates; Ben Bolstad; Marcel Dettling; Sandrine Dudoit; Byron Ellis; Laurent Gautier; Yongchao Ge; Jeff Gentry; Kurt Hornik; Torsten Hothorn; Wolfgang Huber; Stefano Iacus; Rafael Irizarry; Friedrich Leisch; Cheng Li; Martin Maechler; Anthony J Rossini; Gunther Sawitzki; Colin Smith; Gordon Smyth; Luke Tierney; Jean Y H Yang; Jianhua Zhang
Journal:  Genome Biol       Date:  2004-09-15       Impact factor: 13.583

10.  Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women.

Authors:  Unhee Lim; Stephen D Turner; Adrian A Franke; Robert V Cooney; Lynne R Wilkens; Thomas Ernst; Cheryl L Albright; Rachel Novotny; Linda Chang; Laurence N Kolonel; Suzanne P Murphy; Loïc Le Marchand
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

View more
  5 in total

1.  Aryl-Hydrocarbon Receptor Repressor Gene in Primary Graft Dysfunction after Lung Transplantation.

Authors:  Michaela R Anderson; Ethan A Edwin; Joshua M Diamond; Anthony Ferrante; Joshua Sonett; Frank D'Ovidio; Selim Arcasoy; Edward Cantu; Jason D Christie; David J Lederer
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

Review 2.  Protein biomarkers associated with primary graft dysfunction following lung transplantation.

Authors:  B C S Hamilton; J Kukreja; L B Ware; M A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-27       Impact factor: 5.464

3.  Thoracic Visceral Adipose Tissue Area and Pulmonary Hypertension in Lung Transplant Candidates. The Lung Transplant Body Composition Study.

Authors:  Nadine Al-Naamani; Hao-Min Pan; Michaela R Anderson; Drew A Torigian; Yubing Tong; Michelle Oyster; Mary K Porteous; Scott Palmer; Selim M Arcasoy; Joshua M Diamond; Jayaram K Udupa; Jason D Christie; David J Lederer; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2020-11

4.  Genome-wide expression of the residual lung reacting to experimental Pneumonectomy.

Authors:  Valerio Napolioni; Fortunato Bianconi; Rossella Potenza; Francesco M Carpi; Vienna Ludovini; Matteo Picciolini; Francesca R Tofanetti; Antonello Bufalari; Stefano Pallotti; Camilla Poggi; Marco Anile; Niccolò Daddi; Federico Venuta; Francesco Puma; Jacopo Vannucci
Journal:  BMC Genomics       Date:  2021-12-06       Impact factor: 3.969

5.  PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation.

Authors:  Jizhang Yu; Heng Xu; Jikai Cui; Shanshan Chen; Hao Zhang; Yanqiang Zou; Jing Zhao; Sheng Le; Lang Jiang; Zhang Chen; Hao Liu; Dan Zhang; Jiahong Xia; Jie Wu
Journal:  Aging (Albany NY)       Date:  2020-06-15       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.